# Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

> **NCT05174312** · NA · COMPLETED · sponsor: **Reprieve Cardiovascular, Inc** · enrollment: 100 (actual)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DEVICE:** Reprieve Decongestion Management System
- **DRUG:** Diuretic

## Key facts

- **NCT ID:** NCT05174312
- **Lead sponsor:** Reprieve Cardiovascular, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-11
- **Primary completion:** 2025-01-10
- **Final completion:** 2025-01-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05174312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05174312, "Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05174312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*